1. http://www. ClinicalTrials.gov
2. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267–74.
3. Rasmusson I, Le Blanc K, Sundberg B, Ringden O. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol 2007; 65: 336–43.
4. Raffaghello L, Bianchi G, Bertolotto M et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 2008; 26: 151–62
5. Polak J. Cell Therapy for Lung Disease. London: Imperial College Press, 2010.
6. Liu X, Engelhardt JF. The glandular stem/progenitor cell niche in airway development and repair. Proc Am Thorac Soc 2008; 5: 682–8.
7. Wang J, Edeen K, Manzer R. Differentiated human alveolar epithelial cells and reversibility of their phenotype in vitro. Am J Respir Cell Mol Biol 2007; 36 (6): 661–8
8. Willis BC, Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 293 (3): L525–34.
9. Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004; 116: 769–78.
10. Lunde K et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199–209.
11. Kotton DN, Ma BY, Cardoso WV et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 2001; 128: 5181–8.
12. Wang G, Bunnell BA, Painter RG et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci USA 2005; 102: 186–91.
13. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369–77.
14. Kotton DN, Fabian AJ, Mulligan RC. Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol 2005; 33: 328–34.
15. Loi R, Beckett T, Goncz KK et al. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Respir Crit Care Med 2006; 173: 171–9.
16. Lee JW, Gupta N, Serikov V. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther 2009; 9 (10): 1259–70.
17. Sala E, Villena C, Balaguer C et al. Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD. Lung 2010; 188 (4): 331–8.
18. Palange P, Testa U, Huertas A et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J 2006; 27 (3): 529–41.
19. Huertas A, Testa U, Riccioni R. Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-BMI. Respir Physiol Neurobiol 2010; 170 (1): 23–31.
20. Аверьянов А.В. Эмфизема легких у больных ХОБЛ: аспекты патогенеза, диагностики и лечения. Дис. … д-ра мед. наук. M., 2008.
21. Ishizawa K, Kubo H, Yamada M et al. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett 2004; 556: 249–52.
22. Zhen G, Liu H, Gu N, Zhang H. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front Biosci 2008; 13: 3415–22.
23. Schweitzer K, Johnstone BH, Garrison J et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med 2011; 183: 215–25.
24. Ingenito EP, Tsai L, Murthy S et al. Autologous lung-derived mesenchymal stem cell transplantation in experimental emphysema. Cell Transplant 2011; p. 1–44.
25. http://osir.client.shareholder.com
26. Ribeiro-Paes J, Bilaqui A, Greco O. Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema. Int J COPD 2011; 6: 64–71.
27. Moeller A, Gilpin SE, Ask K et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179 (7): 588–94.
28. Andersson-Sjöland A, de Alba CG, Nihlberg K et al. Fibrocytes are a potential source of lung fibroblasts in idiopatic pulmonary fibrosis. Int J Biochem Cell Biol 2008; 40: 2129–40.
29. Spees JL, Pociask DA, Sullivan DE et al. Engraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosis. Am J Respir Crit. Care Med 2007; 176: 385–94.
30. Moodley Y, Ilancheran S, Samuel C. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair Am J Respir Crit Care Med 2010; 182 (5): 643–51.
31. Moodley Y, Atienza D, Manuelpillai U et al. Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-induced lung injury. Am J Pathol 2009; 175 (1): 303–13.
32. Курсова Л.В., Конопляников А.Г., Пасов В.В. и др. Возможности применения аутологичных мезенхимальных стволовых клеток в лечении лучевых повреждений легких. Клеточные технологии в биологии и медицине. 2009; 6 (2): 108–12.
33. Rochefort GY, Delorme B, Lopez A. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 2006; 24 (10): 2202–8.
34. Firth AL, Yao W, Ogawa A. Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension Am J Physiol Cell Physiol 2010; 298 (5): 1217–25.
35. Karra R, Vemullapalli S, Dong C et al. Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci USA 2005; 102: 16789–94.
36. Umar S, de Visser YP, Steendijk P. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009; 297 (5): H1606–16.
37. He ZX, Wang HW, Shang F et al. Administrating bone marrow mesenchymal stem cells to treat the experimental pulmonary arterial hypertension in rats. Zhonghua Yi Xue Za Zhi 2009; 89 (30): 2110–5.
38. Kanki-Horimoto S, Horimoto H, Mieno S et al. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 2006; 114 (Suppl. 1): I181–5.
39. Tamm M, Gratwohl A, Tichelli A et al. Autologous haemopoietic stem cell transplantation in a patient with severepulmonary hypertension complicating connective tissue disease. Ann Rheum Dis 1996; 55: 779–80.
40. Wang XX, Zhang FR, Shang YP et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 2007; 49: 1566–71.
41. Mao M, Wang SN, Lv XJ et al. Intravenous delivery of bone marrow-derived endothelial progenitor cells improves survival and attenuates lipopolysaccharide-induced lung injury in rats. Shock 2010; 34 (2): 196–204.
42. Lam CF, Liu YC, Hsu JK. Autologous transplantation of endothelial progenitor cells attenuates acute lung injury in rabbits. Anesthesiology 2008; 108 (3): 392–401.
43. Lee JW, Fang X, Gupta N. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009; 106 (38): 16357–62.
44. Xu J, Woods CR, Mora AL et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Phy-siol Lung Cell Mol Physiol 2007; 293: L131–41.
45. Nemeth K, Leelahavanichkul A, Yuen PS. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15 (1): 42–9.
46. Mei SH, Haitsma JJ, Dos Santos CC et al. Mesenchymal Stem Cells Reduce Inflammation while Enhancing Bacterial Clearance and Improving Survival in Sepsis. Am J Respir Crit Care Med 2010; 182 (8): 1047–57.
47. Alexander BL, Ali RR, Alton EW et al. Progress and prospects: gene therapy clinical trials (part 1). Gene Ther 2007; 14 (20): 1439–47.
48. Ерохин В.В., Цыб А.Ф., Чуканов В.И. и др. Клеточные технологии в терапии хронического мультирезистентного туберкулеза легких. Проблемы туберкулеза и болезней легких. 2006; 8: 3–5.
49. Васильева И.А., Коноплянников А.Г., Ерохин В.В. и др. Лечебный эффект системной трансплантации культивируемых аутогенных мезенхимальных стволовых клеток костного мозга у больных с резистентными формами туберкулеза легких. Клеточная транспланталогия и тканевая инженерия. 2007; 4 (1): 77–80.
50. Maurya DK, Doi C, Kawabata A et al. Therapy with un-engineered naive rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma BMC. Cancer 2010; 10: 590.
51. Loebinger MR, Kyrtatos PG, Turmaine M. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompa-tible magnetic nanoparticles. Cancer Res 2009; 69 (23): 8862–7.
52. Loebinger MR, Eddaoudi A, Davies D, Janes SM. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res 2009; 69 (10): 4134–42.
53. Grisendi G, Bussolari R, Cafarelli L et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Res 2010; 70 (9): 3718–29.
54. Lakshmipathy U et al. Emerging technology platforms for stem cells. New Jersey: John Wiley & Sons, Inc., 2009.
55. Eramo A, Lotti F, Sette G et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15: 504–14.
56. Mimeault M, Hauke R, Metha PP, Batra SK. Recent advances in cancer stem/progenitor cell research: therapeutic implications to overcome resistance to the most aggressive cancers. J Cell Mol Med 2007; 11: 981–1011.
57. Jeon ES, Lee IH, Heo SC. Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism. Biochim Biophys Acta 2010; 1801 (11): 1205–13.
58. Bajada S, Mazakova I, Richardson JB, Ashammakhi N. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2008; 2 (4): 169–83.
59. Petersen TH, Calle EA, Zhao L et al. Tissue-Engineered Lungs for in Vivo Implantation Science 2010; 329 (5991): 538–41.
60. Macchiarini P, Jungebluth P, Go T et al. Clinical transplantation of a tissue engineered airway. Lancet 2008; 372: 2023–30.

А.В.Аверьянов 

ФГУЗ Клиническая больница №83 ФМБА России